LGC

This article is about the British analytical company. For other uses, see LGC (disambiguation).
LGC Ltd
Abbreviation LGC
Motto Science for a Safer World
Formation February 1996 (formerly Laboratory of the Government Chemist; executive agency established in 1842)
Legal status Private limited company
Location
Region served
England, Wales, Scotland and Northern Ireland
Membership
Forensic scientists, Chemists, Biologists
Chief Executive
 Tim Robinson
Parent organization
 KKR
Website LGC

LGC is an international life sciences measurement and testing company with leading positions in growing markets.

LGC provides a range of measurement products and services which underpin the safety, health and security of the public, including reference materials and proficiency testing, genomics reagents and instrumentation, and expert sample analysis and interpretation. LGC serves customers across a number of end markets including Pharmaceuticals, Agricultural Biotechnology, Diagnostics, Food, Environment, Government and Academia.

It was formed in 1996 after the privatisation of the Laboratory of the Government Chemist, and still has a statutory role as the Government Chemist. Since privatisation it has expanded from 270 staff in 1996 to over 2000 in 2016 and is Europe's largest, independent analytical laboratory.[1]

LGC participates in the European Reference Materials consortium, together with the Institute for Reference Materials and Measurements (IRMM) of the European Commission's Directorate General Joint Research Centre and the Bundesanstalt für Materialforschung und -prüfung (BAM).

Its operations are extensively accredited to international quality standards such as ISO/IEC 17025, ISO 13485, GMP, GLP and ISO Guide 34.

LGC was acquired from LGV Capital by private equity firm Bridgepoint in February 2010 for £257,000,000.[2] The acquisition was predicated on LGC's growth prospects in the face of "increasing regulation and the trend to outsourcing within both the public and private sectors."[2]

In 2015, LGC "agreed to acquire" Biosearch Technologies, which had a complimentary range of products in the medical diagnostics and research market, the aim being to create a "one-stop shop for a wide variety of genomics applications".[3]

Corporate governance

As of 2015, LGC's chief executive officer (CEO) was Tim Robinson.[3] At the time of LGC's change of ownership to Bridgepoint in 2010, David Richards held the CEO role.[2]

See also

References

  1. ↑ "About LGC: History". LGC. Retrieved 30 June 2010.
  2. 1 2 3 "Bridgepoint acquires LGC" (Press release). Bridgepoint. May 2, 2010. Archived from the original on 8 November 2010.
  3. 1 2 Staff (May 15, 2015). "LGC Acquires Bioresearch Technologies". Industry Watch. Genetic Engineering & Biotechnology News. 35 (10). p. 10.

Coordinates: 51°25′25″N 0°20′32″W / 51.42361°N 0.34222°W / 51.42361; -0.34222

This article is issued from Wikipedia - version of the 11/22/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.